Published in Bull World Health Organ on January 01, 1963
Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ (1969) 12.55
Comparison of improved BACTEC and Lowenstein-Jensen media for culture of mycobacteria from clinical specimens. J Clin Microbiol (1990) 4.31
Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2002) 4.10
Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution. Antimicrob Agents Chemother (1982) 3.82
Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appl Microbiol (1970) 3.65
Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice. Antimicrob Agents Chemother (1993) 2.97
Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis. J Clin Microbiol (2006) 2.88
Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. J Clin Microbiol (1986) 2.87
Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods. J Clin Microbiol (1985) 2.68
Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J Clin Microbiol (2002) 2.36
Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat Genet (2014) 2.29
Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis. Clin Infect Dis (2009) 2.25
Rapid radiometric method of testing susceptibility of mycobacteria and slow-growing fungi to antimicrobial agents. Antimicrob Agents Chemother (1974) 2.22
In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex. Antimicrob Agents Chemother (1989) 2.22
Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods. Antimicrob Agents Chemother (1985) 2.07
Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations. J Clin Microbiol (2013) 1.99
Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation. J Clin Microbiol (2009) 1.98
New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability. Antimicrob Agents Chemother (2010) 1.95
Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother (2003) 1.93
Rapid susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP. Antimicrob Agents Chemother (1988) 1.76
Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. Antimicrob Agents Chemother (2005) 1.75
An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future. Antimicrob Agents Chemother (2010) 1.71
Prospective study of mycobacterial infections in patients with cystic fibrosis. Thorax (1990) 1.65
Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults. PLoS One (2008) 1.51
The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance. Antimicrob Agents Chemother (2012) 1.48
High-throughput screen for detecting antimycobacterial agents. Antimicrob Agents Chemother (1995) 1.46
Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean Patients with drug-resistant tuberculosis. J Clin Microbiol (2009) 1.43
MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs. Antimicrob Agents Chemother (1988) 1.42
Tuberculosis: drug resistance, fitness, and strategies for global control. Eur J Pediatr (2007) 1.41
Evaluation of streptomycin and ethambutol concentrations for susceptibility testing of Mycobacterium tuberculosis by radiometric and conventional procedures. J Clin Microbiol (1986) 1.38
Radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis in egg-yolk-enriched BACTEC 12A medium. Antimicrob Agents Chemother (1988) 1.37
The pyrazinamide susceptibility breakpoint above which combination therapy fails. J Antimicrob Chemother (2014) 1.31
Can molecular methods detect 1% isoniazid resistance in Mycobacterium tuberculosis? J Clin Microbiol (2013) 1.25
Evaluation of the Sensititre MycoTB plate for susceptibility testing of the Mycobacterium tuberculosis complex against first- and second-line agents. J Clin Microbiol (2012) 1.24
Performance of tuberculosis drug susceptibility testing in U.S. laboratories from 1994 to 2008. J Clin Microbiol (2012) 1.22
Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry. J Clin Microbiol (1995) 1.17
Rifampin heteroresistance in Mycobacterium tuberculosis cultures as detected by phenotypic and genotypic drug susceptibility test methods. J Clin Microbiol (2013) 1.16
Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China. J Antimicrob Chemother (2011) 1.15
High prevalence of multidrug-resistant tuberculosis in Georgia. Int J Infect Dis (2008) 1.13
Development of a rapid method for determining the susceptibility of Mycobacterium tuberculosis to isoniazid using the Gen-Probe DNA Hybridization System. Antimicrob Agents Chemother (1989) 1.13
Redefining multidrug-resistant tuberculosis based on clinical response to combination therapy. Antimicrob Agents Chemother (2014) 1.13
Systematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother (2012) 1.13
Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs. Antimicrob Agents Chemother (2013) 1.10
In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis. Antimicrob Agents Chemother (2007) 1.09
Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours. J Clin Microbiol (1998) 1.09
Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis. Curr Opin Infect Dis (2008) 1.07
Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India. BMC Infect Dis (2013) 1.06
Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs. Braz J Microbiol (2008) 1.05
Susceptibility of mycobacteria to rifampin. Antimicrob Agents Chemother (1972) 1.04
Extensive transmission of isoniazid resistant M. tuberculosis and its association with increased multidrug-resistant TB in two rural counties of eastern China: a molecular epidemiological study. BMC Infect Dis (2010) 1.02
Rapid detection of ofloxacin resistance in Mycobacterium tuberculosis by two low-cost colorimetric methods: resazurin and nitrate reductase assays. J Clin Microbiol (2005) 1.02
Antimycobacterial susceptibility testing methods for natural products research. Braz J Microbiol (2010) 1.01
Molecular diversity of Mycobacterium tuberculosis isolates from patients with tuberculosis in Honduras. BMC Microbiol (2010) 0.99
A controlled comparison of a twice-weekly and three once-weekly regimens in the initial treatment of pulmonary tuberculosis. Bull World Health Organ (1970) 0.98
Clinical characteristics and treatment outcomes of patients with low- and high-concentration isoniazid-monoresistant tuberculosis. PLoS One (2014) 0.95
Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs. BMC Infect Dis (2011) 0.95
Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe. PLoS One (2013) 0.94
Proficiency analysis of drug susceptibility testing by national-level tuberculosis reference laboratories from 1995 to 2003. J Clin Microbiol (2007) 0.92
Evaluation of fluoromycobacteriophages for detecting drug resistance in Mycobacterium tuberculosis. J Clin Microbiol (2011) 0.91
Safe determination of susceptibility of Mycobacterium tuberculosis to antimycobacterial agents by flow cytometry. J Clin Microbiol (1999) 0.90
Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa. BMC Infect Dis (2012) 0.90
PCR-single-strand conformational polymorphism method for rapid detection of rifampin-resistant Mycobacterium tuberculosis: systematic review and meta-analysis. J Clin Microbiol (2010) 0.89
Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis. Proteome Sci (2010) 0.89
Rapid detection of Mycobacterium tuberculosis resistance to second-line drugs by use of the manual mycobacterium growth indicator tube system. J Clin Microbiol (2008) 0.89
French multicenter study involving eight test sites for radiometric determination of activities of 10 antimicrobial agents against Mycobacterium avium complex. Antimicrob Agents Chemother (1995) 0.88
From multidrug- to extensively drug-resistant tuberculosis: upward trends as seen from a 15-year nationwide study. PLoS One (2013) 0.88
Ciprofloxacin susceptibility testing by MIC and disk elution of drug-resistant Mycobacterium tuberculosis and Mycobacterium avium complex. Antimicrob Agents Chemother (1993) 0.86
Drug-resistant pulmonary tuberculosis in a tertiary referral hospital in Korea. Korean J Intern Med (1999) 0.85
Evaluation of BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to first-line drugs in China. PLoS One (2014) 0.85
Antitubercular drug resistance in four healthcare facilities in North India. J Health Popul Nutr (2011) 0.85
Mycolic acid index susceptibility method for Mycobacterium tuberculosis. J Clin Microbiol (2001) 0.84
Analysis of intracellular expressed proteins of Mycobacterium tuberculosis clinical isolates. Proteome Sci (2012) 0.84
Molecular epidemiology of Mycobacterium tuberculosis, Buenos Aires, Argentina. Emerg Infect Dis (2011) 0.84
Evaluation of a novel kit for use with the BacT/ALERT 3D system for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2006) 0.84
Utility of Gastric Lavage for Diagnosis of Tuberculosis in Patients who are Unable to Expectorate Sputum. J Glob Infect Dis (2011) 0.84
Rapid susceptibility testing for nontuberculosis mycobacteria using flow cytometry. J Clin Microbiol (1996) 0.83
Rifampin-isoniazid oligonucleotide typing: an alternative format for rapid detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol (2010) 0.83
Mycobacterium chelonei infection: successful treatment based on a radiometric susceptibility test. Antimicrob Agents Chemother (1977) 0.82
Evolution and transmission patterns of extensively drug-resistant tuberculosis in China. Antimicrob Agents Chemother (2014) 0.82
The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, Russia. PLoS One (2016) 0.82
Current tools available for the diagnosis of drug-resistant tuberculosis. Ther Adv Infect Dis (2016) 0.81
Performance of Clinical Algorithms for Smear-Negative Tuberculosis in HIV-Infected Persons in Ho Chi Minh City, Vietnam. Tuberc Res Treat (2012) 0.81
Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010-2011. Emerg Infect Dis (2015) 0.81
Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin. Antimicrob Agents Chemother (2016) 0.80
Spoligotyping and drug resistance patterns of Mycobacterium tuberculosis isolates from five provinces of Iran. Microbiologyopen (2013) 0.80
Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates. J Clin Microbiol (2007) 0.80
Direct nitrate reductase assay versus microscopic observation drug susceptibility test for rapid detection of MDR-TB in Uganda. PLoS One (2011) 0.80
A study of Mycobacterium tuberculosis genotypic diversity & drug resistance mutations in Varanasi, north India. Indian J Med Res (2014) 0.79
Challenges and controversies in defining totally drug-resistant tuberculosis. Emerg Infect Dis (2012) 0.78
Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study. J Clin Microbiol (2016) 0.77
Molecular patterns of multidrug resistance of Mycobacterium tuberculosis in Georgia. Int J Mycobacteriol (2013) 0.77
Optimization of a nucleic acid-based reporter system to detect Mycobacterium tuberculosis antibiotic sensitivity. Antimicrob Agents Chemother (2014) 0.77
Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda. Infect Genet Evol (2016) 0.77
Comparison of techniques for antimicrobial susceptibility testing of mycobacteria. J Clin Pathol (1993) 0.77
Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe. Int J Tuberc Lung Dis (2016) 0.77
Evaluation of the performance of nitrate reductase assay for rapid drug-susceptibility testing of mycobacterium tuberculosis in north India. J Health Popul Nutr (2011) 0.76
Occurrence and distribution of antibiotic-resistant bacteria and transfer of resistance genes in Lake Taihu. Microbes Environ (2013) 0.76
Susceptibility Profiles of Mycobacterium ulcerans Isolates to Streptomycin and Rifampicin in Two Districts of the Eastern Region of Ghana. Int J Microbiol (2016) 0.75
Nitrate reductase assay using sodium nitrate for rapid detection of multidrug resistant tuberculosis. Braz J Microbiol (2012) 0.75
In-house, simple & economical phage technique for rapid detection of rifampicin, isoniazid, ethambutol, streptomycin & ciprofloxacin drug resistance using Mycobacterium tuberculosis isolates. Indian J Med Res (2012) 0.75
[Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation]. Rev Tuberc Pneumol (Paris) (1963) 5.58
The prevalence of drug-resistant tubercle bacilli in untreated patients with pulmonary tuberculosis; a national survey, 1955-56. Tubercle (1957) 3.22
The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. I. Homogeneity of the investigation and a critique of the virulence test. Bull World Health Organ (1961) 3.03
A comparison of the virulence in guinea-pigs of South Indian and British tubercle bacilli. Tubercle (1960) 2.95
[The detection of isoniazid in urine]. Tubercle (1958) 2.32
Bacteriophage active against virulent Mycobacterium tuberculosis. I. Isolation and activity. Am J Public Health Nations Health (1954) 2.28
VIRULENCE IN THE GUINEA-PIG, SUSCEPTIBILITY TO HYDROGEN PEROXIDE, AND CATALASE ACTIVITY OF ISONIAZID-SENSITIVE TUBERCLE BACILLI FROM SOUTH INDIAN AND BRITISH PATIENTS. J Pathol Bacteriol (1963) 2.21
The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. 2. Comparison with virulence of tubercle bacilli from British patients. Bull World Health Organ (1961) 2.21
Examination of smears for tubercle bacilli by fluorescence microscopy. Indian J Med Res (1959) 2.09
The changing spectrum of nocardiosis. A review and presentation of nine cases. Am Rev Respir Dis (1961) 2.02
A comparison of the sensitivity to p-aminosalicylic acid of tubercle bacilli from South Indian and British patients. Bull World Health Organ (1960) 2.02
The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. 3. Virulence related to pretreatment status of disease and to response to chemotherapy. Bull World Health Organ (1961) 1.93
Isoniazid-resistant strains of tubercle bacili; their development and stability. Lancet (1953) 1.82
Comparison of techniques for measuring the isoniazid resistance of tubercle bacilli. J Clin Pathol (1953) 1.82
Lysogeny in the mycobacteria. 1. The establishment of lysogeny. Am Rev Respir Dis (1960) 1.72
Viable counting of Mycobacterium tuberculosis in a silica gel medium. J Gen Microbiol (1957) 1.72
PRIMARY DRUG RESISTANCE IN TUBERCULOSIS. Am Rev Respir Dis (1964) 1.68
The tellurite zonal phenomenon of mycobacterial lysis observed in a BCG strain exposed to mycophage My F2P/59. Am Rev Respir Dis (1963) 1.65
Bacteriological aspects of a survey of the incidence of drug-resistant tubercle bacilli among untreated patients. Tubercle (1957) 1.54
The bactericidal activities of antituberculous drugs. Am Rev Tuberc (1956) 1.41
The prevalence of bacterial resistance to isoniazid and to PAS in patients with acute pulmonary tuberculosis presenting for treatment in East Africa. Tubercle (1960) 1.41
[Incidence of wild strains of Mycobacterium tuberculosis in variants resistant to minor antibiotics (p-aminosalicylic acid, ethionamide, cycloserine, viomycin, kanamycin)]. Ann Inst Pasteur (Paris) (1962) 1.39
Electron microscopic studies of mycobacteriophages. Am Rev Tuberc (1957) 1.38
THE EMERGENCE OF ISONIAZID-RESISTANT CULTURES IN PATIENTS WITH PULMONARY TUBERCULOSIS DURING TREATMENT WITH ISONIAZID ALONE OR ISONIAZID PLUS PAS. Bull World Health Organ (1964) 1.34
THE VIRULENCE OF TUBERCLE BACILLI FROM PATIENTS WITH PULMONARY TUBERCULOSIS IN INDIA AND OTHER COUNTRIES. Bull Int Union Tuberc (1964) 1.32
Tubercle bacilli resistant to isoniazid: virulence and response to treatment with isoniazid in guinea-pigs and mice. Br J Exp Pathol (1953) 1.31
The behaviour of mixtures of streptomycin-sensitive and -resistant tubercle bacilli in liquid medium sensitivity tests. Thorax (1950) 1.27
Streptomycin resistance in pulmonary tuberculosis. Br Med J (1948) 1.24
Comparison of solid and liquid medium sensitivity tests of tubercle bacilli to para-aminosalicylic acid. J Clin Pathol (1955) 1.24
Experimental infective pneumoconiosis. V. Massive fibrosis of the lungs produced by coal-mine dust and Mycobacterium tuberculosis var. muris (Vole bacillus). AMA Arch Ind Health (1957) 1.20
Bactericidal activity of streptomycin and isoniazid against tubercle bacilli. Br Med J (1954) 1.19
[Sensitivity of the hamster to BCG bacillus]. Presse Med (1951) 1.19
Experimental infective pneumoconiosis. II. Coal-mine dust with attenuated tubercle bacilli (B.C.G.) in the lungs of immunised guinea-pigs. Br J Exp Pathol (1955) 1.15
Experimental infective pneumoconiosis. IV. Massive pulmonary fibrosis produced by coal-mine dust and isoniazid-resistant tubercle bacilli of low virulence. Br J Exp Pathol (1955) 1.15
Tubercle bacilli resistant to isoniazid; virulence and response to treatment with isoniazid in guinea-pigs. Br Med J (1954) 1.13
Intermittent dosage in the treatment of pulmonary tuberculosis with streptomycin; a report to the Streptomycin in Tuberculosis Committee of the Medical Research Council. Br Med J (1950) 1.12
The bactericidal activities of combinations of streptomycin, isoniazid, p-aminosalicylic acid (PAS), oxytetracycline (terramycin) and viomycin against Mycobacterium tuberculosis. J Gen Microbiol (1955) 1.11
[Sterilization of lesions in osteo-articular tuberculosis by antibacillary chemotherapy]. Rev Tuberc (1957) 1.10
The eradication of tuberculosis: theoretical problems and practical solutions. Tubercle (1962) 1.10
ENHANCEMENT OF VIRULENCE FOR CHICKENS OF BATTEY TYPE OF MYCOBACTERIA BY PREINCUBATION AT 42 C. Am Rev Respir Dis (1964) 1.09
[INCIDENCE AND CHARACTERISTICS OF PRIMARY RESISTANCE IN 2144 CASES OF UNTREATED PULMONARY TUBERCULOSIS FROM DIFFERENT REGIONS OF FRANCE. (PRELIMINARY REPORT OF THE CENTRE D'ETUDE SUR LA R'ESISTANCE PRIMAIRE)]. Rev Tuberc Pneumol (Paris) (1964) 1.07
[BCG and hamster]. Rev Tuberc (1951) 1.07
CHEMOTHERAPY OF TUBERCULOSIS: A BACTERIOLOGIST'S VIEWPOINT. Br Med J (1965) 1.05
Effect of early administration of isoniazid on the immunizing activity of normal BCG and isoniazid-resistant BCG in guinea pigs. Am Rev Tuberc (1957) 1.04
A VERTICAL DIFFUSION METHOD FOR THE MICROBIOLOGICAL ASSAY OF ISONIAZID. J Clin Pathol (1964) 1.02
Experimental infective pneumoconiosis. Arh Hig Rada (1953) 1.02
FURTHER EXPERIMENTS ON LONG-TERM CHEMOTHERAPY OF ADVANCED MURINE TUBERCULOSIS, WITH EMPHASIS ON INTERMITTENT REGIMES. Tubercle (1964) 1.01
Atypical mycobacteria and drug-resistant tubercle bacilli isolated during a survey of untreated patients with pulmonary tuberculosis. Tubercle (1959) 0.99
[The lyophilization of Bacterian antigens for the sero-diagnosis of brucellosis]. Experientia (1952) 0.98
VIRULENCE IN THE GUINEA-PIG AND SUSCEPTIBLITY TO HYDROGEN PEROXIDE OF ISONIAZID-SENSITIVE TUBERCLE BACILLI FROM SOUTH INDIAN PATIENTS. Tubercle (1964) 0.98
The part played by BCG vaccination in reducing the morbidity and mortality rates from tuberculosis in Czechoslovakia. Rev Czech Med (1956) 0.97
Development of streptomycin resistant strains of tubercle bacilli in pulmonary tuberculosis; results of simultaneous sensitivity tests in liquid and on solid media. Thorax (1950) 0.96
[Hazard of transmission of disease in sanatorium]. Rev Tuberc (1953) 0.96
Long-term, two-stage chemotherapy of advanced experimental murine tuberculosis with intermittent regimes during the second stage. Tubercle (1963) 0.96
[A method of associating TB prophylaxis vaccination and chemoprevention; vaccination B.C.G. isoniazido-resistant and isoniazid until the appearance of the vaccine specific resistance]. Rev Tuberc (1955) 0.95
[12 years of experimentation on infection of hamsters by BCG]. Ann Inst Pasteur (Paris) (1963) 0.94
[Effect of early treatment with isoniazid on the immunity induced in guinea pigs by a small dose of standard BCG; further data on the immunizing capacity of isoniazid-resistant BCG]. Ann Inst Pasteur (Paris) (1958) 0.94
[Identification of the sources of contagion in various cases of primary tuberculosis resistance]. Rev Tuberc Pneumol (Paris) (1963) 0.94
Five years' experience with a vaccine prepared from Mycobacterium tuberculosis var. muris. Tubercle (1958) 0.94
The occurrence of independent mutations to different types of streptomycin resistance in Bacterium coli. J Gen Microbiol (1953) 0.93
Bacteriophage susceptibility and cultural characteristics of BCG and other tubercle bacilli. Dis Chest (1955) 0.92
WHO CO-OPERATIVE STUDIES ON A SIMPLE CULTURE TECHNIQUE FOR THE ISOLATION OF MYCOBACTERIA. 1. PREPARATION, LYOPHILIZATION AND RECONSTITUTION OF A SIMPLE SEMI-SYNTHETIC CONCENTRATED LIQUID MEDIUM; CULTURE TECHNIQUE; GROWTH PATTERN OF DIFFERENT MYCOBACTERIA. Bull World Health Organ (1963) 0.92
[Koch's bacillus in resected tuberculous lesions after chemotherapy: 97 cases]. Poumon Coeur (1955) 0.91
Problems of drug resistance. Br Med Bull (1954) 0.88
Bactericidal activity of streptomycin and isoniazid in combination with p-aminosalicylic acid against Mycobacterium tuberculosis. J Gen Microbiol (1955) 0.87
[The antibiotic effect of Escherichia coli on Mycobacterium tuberculosis; chemotherapy of tuberculosis]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1950) 0.87
[Heterogeneity of Escherichia coli strains producing colicine]. Ann Inst Pasteur (Paris) (1962) 0.87
Identification of a new type of colicine (colicine L). Nature (1962) 0.87
[Comparative effects of oral and intravenous p-aminosalicylic acid on the active blood level of isoniazid]. Rev Tuberc (1958) 0.87
The virulence in the guinea-pig of isoniazid-sensitive tubercle bacilli isolated from South Indian patients before treatment and after three months of chemotherapy. Bull World Health Organ (1961) 0.87
[Virulence of tubercle bacilli in vivo from patients treated with isoniazid]. G Ital Chemioter (1955) 0.86
[Preliminary treatment of sputum and gastric lavage matter with Saxholm's pancreatin-desogen solution for the culture of tubercle bacilli]. Beitr Klin Tuberk Spezif Tuberkuloseforsch (1962) 0.86
[Percentage of isoniazid-resistant and streptomycin-resistant variants in wild strains of Mycobacterium tuberculosis on Loewenstein-Jensen medium]. Ann Inst Pasteur (Paris) (1961) 0.86
[Early results of isoniazid therapy as a function of the active blood level of isoniazid; study of 100 cases]. Rev Tuberc (1958) 0.85
Response of patients infected with isoniazid-resistant tubercle bacilli to treatment with isoniazid plus PAS or isoniazid alone. Bull World Health Organ (1961) 0.85
Serial determinations of serum glycoproteins and proteins in the early stages of experimental tuberculosis. J Lab Clin Med (1959) 0.85
Electrophoretic studies of serum proteins and glycoproteins during early stages of experimental tuberculosis. Proc Soc Exp Biol Med (1960) 0.85
VIRULENCE IN THE GUINEA-PIG AND SENSITIVITY TO PAS AND THIACETAZONE OF TUBERCLE BACILLI FROM SOUTH INDIAN PATIENTS WITH PULMONARY TUBERCULOSIS. Tubercle (1964) 0.84
GEL DOUBLE DIFFUSION TESTING FOR TUBERCULOSIS. Am J Clin Pathol (1964) 0.84
DRUG SENSITIVITY-RESISTANCE DETERMINATION AND SIMPLE ENZYMATIC TESTS FOR THE DIFFERENTIATION OF MYCOBACTERIA. Bull World Health Organ (1963) 0.84
[FORMAMIDASE ACTIVITY AND PATHOGENICITY OF MYCOBACTERIA]. C R Hebd Seances Acad Sci (1963) 0.83
COMPARISON OF THE SENSITIVITY TO THIACETAZONE OF TUBERCLE BACILLI FROM PATIENTS IN BRITAIN, EAST AFRICA, SOUTH INDIA AND HONG KONG. Tubercle (1964) 0.83
Cultural characteristics and drug and bacteriophage resistance of avian tubercle bacilli. Am Rev Tuberc (1957) 0.83
[A case of transmission of Koch bacilli from a tuberculous subject to a subject recovered from pulmonary tuberculosis]. Riv Chir Pediatr (1960) 0.83
WHO CO-OPERATIVE STUDIES ON A SIMPLE CULTURE TECHNIQUE FOR THE ISOLATION OF MYCOBACTERIA. 2. COMPARISON OF THE EFFICACY OF LYOPHILIZED LIQUID MEDIUM WITH THAT OF LOEWENSTEIN-JENSEN (L-J) MEDIUM. Bull World Health Organ (1963) 0.83
Studies of bacillary populations in experimental tuberculosis of mice treated by isoniazid. Am Rev Respir Dis (1960) 0.82